140 results
Page 4 of 7
8-K
EX-1.1
4gj98wm
5 Feb 21
Entry into a Material Definitive Agreement
4:39pm
424B2
9a4ji3p pxbvbaa
4 Feb 21
Prospectus for primary offering
12:00am
424B5
cgkcqhxyjyzddfl7n
2 Feb 21
Prospectus supplement for primary offering
4:13pm
8-K
EX-10.1
45xf84bv7l36hyvzcf49
2 Feb 21
Entry into a Material Definitive Agreement
4:01pm
8-K
EX-99.1
uds27k4ofatv3cdl80a
4 Jan 21
Krystal Biotech Appoints Dr. Chris Mason and Dr. Jing Marantz to its Board of Directors
8:15am
8-K
EX-1.1
zh9f7 btzlz5g
31 Dec 20
Entry into a Material Definitive Agreement
5:28pm
424B5
uf42ks40kv9nf
31 Dec 20
Prospectus supplement for primary offering
4:39pm
8-K
EX-99.2
5xb2o4 nvowg4s09n7
9 Nov 20
Krystal Biotech Reports Third Quarter 2020 Financial Results and Provides Update on Operational Progress
8:32am